Gradual Vs. Rapid Buprenorphine Detoxification - 2
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00000220
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to determine an optimal detoxification dose reduction schedule with buprenorphine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug use Retention Observed withdrawal rating Opioid agonist rating Opioid antagonist rating
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Treatment Research Center
🇺🇸Burlington, Vermont, United States